Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Nanobiotix (NANO)
Price€24.34Cached quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | €29.6M | −€11.6M | €30.1M | €4.8M | €2.6M | €2.5M | €2.5M | €3.5M |
| Research & development | €23.1M | €40.5M | €38.4M | €32.6M | €30.4M | €24.3M | €30.4M | €20.9M |
| Operating expenses | €43.4M | €61.2M | €63.0M | €51.5M | €55.2M | €38.9M | €49.3M | €33.5M |
| Operating income | −€10.8M | −€68.4M | −€26.8M | −€46.7M | −€52.6M | −€36.4M | −€46.8M | −€30.1M |
| Operating margin | −36.49% | — | −89.09% | −977.85% | −1,986.36% | −1,450.16% | −1,840.97% | −864.24% |
| EBITDA | −€9.3M | −€66.8M | −€25.3M | −€45.2M | −€51.0M | −€34.7M | −€45.0M | −€29.4M |
| EBITDA margin | −31.45% | — | −84.06% | −946.44% | −1,927.43% | −1,380.33% | −1,771.43% | −846.45% |
| Net income | −€24.0M | −€68.1M | −€39.7M | −€57.0M | −€47.0M | −€33.6M | −€50.9M | −€30.3M |
| Net profit margin | −80.83% | — | −132.08% | −1,194.33% | −1,775.71% | −1,337.18% | −2,003.74% | −872.23% |
| Basic EPSper basic share | -€0.50 | -€1.44 | -€1.08 | -€1.64 | -€1.35 | -€1.38 | -€0.00 | -€0.00 |
| Diluted EPSper diluted share | -€0.50 | -€1.44 | -€1.08 | -€1.64 | -€1.35 | -€1.38 | -€0.00 | -€0.00 |
Owners
Reported shareholders and owner groups
32.57%of company shares
French Institutional InvestorsSource updated Apr 2, 2026
View holders
| Holder | Ownership |
|---|---|
French Institutional Investors | 32.57%Apr 2, 2026 |
Managers and Associates | 4.64%Apr 2, 2026 |
These Euronext company-profile figures report shares in the company's capital. Named holders and owner groups are shown as published; free float, treasury shares, and unspecified holders are excluded from the colored segments.
Gray completes the 100% scale; it is not an estimate of other owners.
Source: Euronext / Cofisem ↗Checked Sep 27, 2026